IMF Launches Initiative to Improve Outcomes in Multiple Myeloma Among Black Americans - The ASCO Post Read more about IMF Launches Initiative to Improve Outcomes in Multiple Myeloma Among Black Americans - The ASCO PostAdd new comment
With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Read more about With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Add new comment
The International Myeloma Foundation (IMF) Sparks a Season for Change with the Most Impactful Myeloma Action Month Ever Read more about The International Myeloma Foundation (IMF) Sparks a Season for Change with the Most Impactful Myeloma Action Month EverAdd new comment
European Commission (EC) Approves Conditional Marketing Authorization for NEXPOVIO (selinexor) Read more about European Commission (EC) Approves Conditional Marketing Authorization for NEXPOVIO (selinexor)Add new comment
International Myeloma Foundation Says FDA Approval of Bristol Myers Squibb’s and bluebird bio's CAR T-Cell Immunotherapy Treatment for Multiple Myeloma Is Welcome News for Patients Read more about International Myeloma Foundation Says FDA Approval of Bristol Myers Squibb’s and bluebird bio's CAR T-Cell Immunotherapy Treatment for Multiple Myeloma Is Welcome News for PatientsAdd new comment
International Myeloma Foundation Launches “M-Power Charlotte” to Improve Outcomes in Multiple Myeloma, a Cancer That Disproportionately Affects African Americans Read more about International Myeloma Foundation Launches “M-Power Charlotte” to Improve Outcomes in Multiple Myeloma, a Cancer That Disproportionately Affects African AmericansAdd new comment
This International Women’s Day the International Myeloma Foundation (IMF) Proudly Recognizes Our President, Founder, and CEO Susie Durie Read more about This International Women’s Day the International Myeloma Foundation (IMF) Proudly Recognizes Our President, Founder, and CEO Susie DurieAdd new comment
International Myeloma Foundation (IMF) Launches 31 Days of Resilience Campaign for Myeloma Action Month in March 2021 Read more about International Myeloma Foundation (IMF) Launches 31 Days of Resilience Campaign for Myeloma Action Month in March 2021Add new comment
Learning from Iceland's Model for Genetic Research Read more about Learning from Iceland's Model for Genetic ResearchAdd new comment
Submission of Biologics License Application to FDA for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and/or Refractory Myeloma Has Been Initiated Read more about Submission of Biologics License Application to FDA for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and/or Refractory Myeloma Has Been InitiatedAdd new comment
